- Investing Ideas
- /
- Global Undervalued over 20% based on DCF
Global Undervalued over 20% based on DCF
UPDATED Apr 26, 2024
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
5,362 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
AMZN | US$179.62 | 2.9% | 70.3% | US$1.9t | US$210.77 | PE61.4x | E21.6% | n/a | Retail | ||
META | US$443.29 | -7.9% | 84.5% | US$1.1t | US$523.11 | PE24.6x | E12.2% | 0.5% | Media | ||
JPM | US$193.49 | 4.1% | 40.0% | US$555.7b | US$206.36 | PB1.8x | E-1.5% | 2.4% | Banks | ||
WMT | US$60.16 | 1.1% | 19.5% | US$484.9b | US$65.08 | PE31.3x | E10.7% | 1.4% | Consumer Retailing | ||
700 | HK$348.40 | 14.7% | 1.2% | HK$3.2t | HK$418.15 | PE26.1x | E15.0% | 1.0% | Media | ||
PG | US$161.29 | 2.0% | 3.1% | US$380.7b | US$170.01 | PE25.6x | E7.2% | 2.3% | Household | ||
JNJ | US$146.14 | -1.2% | -10.7% | US$352.2b | US$173.60 | PE18.4x | E5.1% | 3.4% | Pharmaceuticals & Biotech | ||
COST | US$729.18 | 2.8% | 44.9% | US$323.4b | US$776.41 | PE47.6x | E7.5% | 0.6% | Consumer Retailing | ||
CVX | US$165.89 | 3.7% | -1.6% | US$306.5b | US$181.37 | PE15.1x | E3.1% | 3.9% | Energy | ||
600519 | CN¥1,709.43 | 3.8% | -2.9% | CN¥2.1t | CN¥2,154.31 | PE28.7x | E12.8% | 2.9% | Food, Beverage & Tobacco | ||
KO | US$61.74 | 2.6% | -3.8% | US$266.2b | US$66.14 | PE24.8x | E7.5% | 3.1% | Food, Beverage & Tobacco | ||
CRM | US$274.29 | 1.4% | 38.3% | US$266.1b | US$337.22 | PE64.3x | E18.8% | 0.6% | Software | ||
NESN | CHF92.70 | -2.7% | -19.1% | CHF238.4b | CHF108.54 | PE21.3x | E7.1% | 3.2% | Food, Beverage & Tobacco | ||
857 | HK$7.54 | 0.7% | 38.9% | HK$2.0t | HK$7.29 | PE7.9x | E-5.2% | 6.3% | Energy | ||
PEP | US$175.58 | 0.8% | -8.0% | US$241.4b | US$186.95 | PE26.3x | E9.5% | 2.9% | Food, Beverage & Tobacco | ||
SHEL | UK£29.04 | 1.8% | 18.4% | UK£186.1b | UK£31.57 | PE12x | E4.0% | 3.8% | Energy | ||
AZN | UK£119.88 | 9.5% | 2.1% | UK£185.8b | UK£131.52 | PE36.7x | E16.5% | 2.1% | Pharmaceuticals & Biotech | ||
SAP | €174.00 | 4.9% | 41.6% | €201.9b | €186.58 | PE78.4x | E33.2% | 1.3% | Software | ||
WFC | US$59.91 | -0.7% | 50.7% | US$209.8b | US$62.30 | PB1.3x | E3.5% | 2.3% | Banks | ||
BABA | US$75.55 | 9.4% | -10.8% | US$183.9b | US$104.98 | PE13.3x | E10.7% | 1.3% | Retail | ||
INTU | US$636.55 | 5.2% | 43.4% | US$178.2b | US$693.63 | PE64.3x | E17.4% | 0.6% | Software | ||
CAT | US$343.38 | -3.2% | 56.9% | US$171.5b | US$326.59 | PE15.2x | E-2.6% | 1.5% | Capital Goods | ||
IBM | US$167.13 | -8.0% | 32.2% | US$153.2b | US$182.87 | PE18.8x | E3.7% | 4.0% | Software | ||
SIE | €177.62 | 2.7% | 19.3% | €139.3b | €190.83 | PE15.8x | E3.8% | 2.6% | Capital Goods |